NATO Summit Meeting in Chicago, and More from CRS
The North Atlantic Treaty Organization will hold its 2012 summit meeting in Chicago on May 20-21. The meeting, hosted by President Obama, will be closed to the public. The assembled heads of state are expected to discuss the future of the conflict in Afghanistan; NATO defense issues, including the possible reconsideration of the role of nuclear weapons in NATO; and other matters.
A preview of the NATO summit meeting was presented in a new report from the Congressional Research Service. See NATO’s Chicago Summit, May 14, 2012.
Other new and updated CRS reports that were obtained by Secrecy News include the following.
Ukraine: Current Issues and U.S. Policy, May 10, 2012
U.S. Assistance Programs in China, May 11, 2012
Bahrain: Reform, Security, and U.S. Policy, May 14, 2012
Medicare Financing, May 11, 2012
Medicare: History of Insolvency Projections, May 11, 2012
Job Growth During the Recovery, May 10, 2012
Foreign Direct Investment in the United States: An Economic Analysis, May 10, 2012
Outsourcing and Insourcing Jobs in the U.S. Economy: Evidence Based on Foreign Investment Data, May 10, 2012
Keystone XL Pipeline Project: Key Issues, May 9, 2012
Immigration of Foreign Nationals with Science, Technology, Engineering, and Mathematics (STEM) Degrees, May 11, 2012
Federal Labor Relations Statutes: An Overview, May 11, 2012
FEMA’s Community Disaster Loan Program: History, Analysis, and Issues for Congress, May 10, 2012
How Measures Are Brought to the House Floor: A Brief Introduction, May 14, 2012
Carbon Capture and Sequestration (CCS): A Primer, May 14, 2012
The Presidential Nominating Process and the National Party Conventions, 2012: Frequently Asked Questions, May 14, 2012
Secrecy News will be back next week.
The absence of consistent voting privileges for patient representatives on Advisory Committees hinders representatives from providing an voice on behalf of the community they represent.
Grant funds research of AI’s impact on nuclear weapons, biosecurity, military autonomy, cybersecurity, and other global issues.
AdComm members note a lack of transparency in recruitment methods, insufficient training, and limited understanding of regulatory procedures.
Internal disagreements present a growing concern about FDA leadership overruling the expert opinions of scientific staff and proceeding with official approvals, thus undermining staff expertise, decreasing agency morale, and potentially diminishing public trust.